Uqora Maximum UTI Pain Relief
- Product NDC
- 73712-114
- Requested package NDC
- 73712-114-12
- 11-digit product format
- 737120114
- Labeler code
- 73712
- Product ID
- 73712-114_426317e7-a926-116a-e063-6294a90a52dc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- PHENAZOPYRIDINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bonafide Health, LLC dba Uqora
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2025-10-27
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 99.5 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Uqora Maximum UTI Pain Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 99.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0EWG668W17 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1094147 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 426317e7-a925-116a-e063-6294a90a52dc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 260b0da6-d3d7-262f-a60f-d4b36d5f1b4d | Product name | 6 | 20251210 |
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73712-114-12 | Uqora Maximum UTI Pain Relief | 1 in 1 CARTON | TABLET | 1 | 1 | |
| 73712-114-12 | Uqora Maximum UTI Pain Relief | 12 in 1 BLISTER PACK | TABLET | 12 | 1 | |
| 73712-114-12 | Uqora Maximum UTI Pain Relief and Flush Convenience Bundle | 12 in 1 BLISTER PACK | TABLET | 12 | 99.5 mg | 1 |
| 73712-114-12 | Uqora Maximum UTI Pain Relief and Flush Convenience Bundle | 1 in 1 CARTON | TABLET | 99.5 mg | 1 | |
| 73712-114-12 | All-In-One UTI Emergency Kit | 12 in 1 BLISTER PACK | TABLET | 12 | 99.5 mg | 1 |
| 73712-114-12 | All-In-One UTI Emergency Kit | 1 in 1 CARTON | TABLET | 99.5 mg | 1 | |
| 73712-114-24 | Uqora Maximum UTI Pain Relief | 1 in 1 CARTON | TABLET | 1 | 1 | |
| 73712-114-24 | Uqora Maximum UTI Pain Relief | 24 in 1 BLISTER PACK | TABLET | 24 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| All-In-One UTI Emergency Kit | METHENAMINE, SODIUM SALICYLATE, AND PHENAZOPYRIDINE HYDROCHLORIDE | Bonafide Health, LLC dba Uqora | 434652a1-583e-d6f7-e063-6394a90aab8a | 2025-11-10 | Warnings | 73712-114-12 73712011412 |
| Uqora Maximum UTI Pain Relief and Flush Convenience Bundle | PHENAZOPYRIDINE HYDROCHLORIDE | Bonafide Health, LLC dba Uqora | 4354dcce-6d85-4584-e063-6294a90a5616 | 2025-11-10 | Warnings | 73712-114-12 73712011412 |
| Uqora Maximum UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Bonafide Health, LLC dba Uqora | 426317e7-a925-116a-e063-6294a90a52dc | 2025-10-27 | Warnings | 73712-114-12 73712-114 73712011412 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1489932 | methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet | PSN | 434652a1-583e-d6f7-e063-6394a90aab8a | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | PSN | 426317e7-a925-116a-e063-6294a90a52dc | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | PSN | 434652a1-583e-d6f7-e063-6394a90aab8a | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | PSN | 4354dcce-6d85-4584-e063-6294a90a5616 | 1 |
| 1489932 | methenamine 162 MG / sodium salicylate 162.5 MG Oral Tablet | SCD | 434652a1-583e-d6f7-e063-6394a90aab8a | 1 |
| 1094147 | phenazopyridine hydrochloride 99.5 MG Oral Tablet | SCD | 426317e7-a925-116a-e063-6294a90a52dc | 1 |
| 1094147 | phenazopyridine hydrochloride 99.5 MG Oral Tablet | SCD | 434652a1-583e-d6f7-e063-6394a90aab8a | 1 |
| 1094147 | phenazopyridine hydrochloride 99.5 MG Oral Tablet | SCD | 4354dcce-6d85-4584-e063-6294a90a5616 | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | SY | 426317e7-a925-116a-e063-6294a90a52dc | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | SY | 434652a1-583e-d6f7-e063-6394a90aab8a | 1 |
| 1094147 | phenazopyridine HCl 99.5 MG Oral Tablet | SY | 4354dcce-6d85-4584-e063-6294a90a5616 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 73712-114-12 | 73712011412 | 1 BLISTER PACK in 1 CARTON (73712-114-12) / 12 TABLET in 1 BLISTER PACK | 1 blister pack | 2025-10-27 | No | No | Current |